By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytRx Corporation 

11726 San Vicente Boulevard
Suite 650
Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS








Company News
Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx (CYTR) Board Of Directors 12/2/2016 8:26:00 AM
CytRx (CYTR) Plans to File NDA for Once-Failed Sarcoma Drug While Columnist Raises Questions Over Efficacy and CEO Salary Amid Struggle 11/30/2016 5:55:30 AM
CytRx (CYTR) Reports Statistically Significant Updated Results From Pivotal Phase 3 Trial Of Aldoxorubicin In Patients With Second-Line Soft Tissue Sarcomas 11/29/2016 6:32:47 AM
CytRx (CYTR) Presents Positive Interim Results From On-Going Phase 1b/2 Aldoxorubicin Combination Clinical Trial At The 2016 CTOS Annual Meeting 11/14/2016 6:29:03 AM
CytRx (CYTR) Reports Third Quarter 2016 Financial Results 11/10/2016 4:19:57 PM
CytRx (CYTR) Presents Interim Results From On-Going Aldoxorubicin Plus Ifosfamide/Mesna Combination Clinical Trial At ESMO 2016 Congress 10/10/2016 7:28:12 AM
CytRx (CYTR) To Present Data At The European Society For Medical Oncology 2016 Congress From Aldoxorubicin Plus Ifosfamide/Mesna Combination Clinical Trial 9/12/2016 10:52:03 AM
CytRx (CYTR) Announces The Completion Of Enrollment In Its Global Phase 2b Clinical Trial Of Aldoxorubicin In Patients With Second-Line Small Cell Lung Cancer 9/7/2016 8:31:21 AM
CytRx (CYTR) To Present At The Rodman & Renshaw 18th Annual Global Investment Conference 9/6/2016 1:48:41 PM
CytRx (CYTR) Reports Second Quarter 2016 Financial Results 7/29/2016 7:56:48 AM
12345678910...
//-->